Role of the glyoxalase system in astrocyte-mediated neuroprotection

Journal of Neuroscience

Volumn 31, Issue 50, 2011, Pages 18338-18352

  Bélanger, Mireille ^a   Yang, Jiangyan ^a   Petit, Jean Marie ^a,c   Laroche, Thierry ^b   Magistretti, Pierre J ^a,c   Allaman, Igor ^a  

^a Brain Mind Institute   (Switzerland)

^b EPFL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; DEOXYGLUCOSE; DIETHYLENETRIAMINE; FRUCTOSE 2, 6 BISPHOSPHATASE; GLUTATHIONE; HYDROXYACYLGLUTATHIONE HYDROLASE; LACTIC ACID; LACTOYLGLUTATHIONE LYASE; LENTIVIRUS VECTOR; METHYLGLYOXAL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; CYTOPROTECTION; LACTOYLGLUTATHIONE LYASE; MICE; NEURONS; THIOLESTER HYDROLASES;

EID: 83455179184     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1249-11.2011     Document Type: Article

References (66)

1. Ahmed N, Battah S, Karachalias N, Babaei-Jadidi R, Horányi M, Baróti K, Hollan S, Thornalley PJ (2003) Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim Biophys Acta 1639:121-132.
2. Allaman I, Pellerin L, Magistretti PJ (2004) Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes. J Neurochem 88:900-908.
3. Allaman I, Gavillet M, Bélanger M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ (2010) Amyloid-β aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30:3326-3338.
4. Allaman I, Bélanger M, Magistretti PJ (2011) Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34:76-87.
5. Almeida A, Almeida J, Bolaños JP, Moncada S (2001) Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A 98:15294-15299.
6. Almeida A, Moncada S, Bolaños JP (2004) Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6:45-51.
7. Barde I, Salmon P, Trono D (2010) Production and titration of lentiviral vectors. Curr Protoc Neurosci 53:4.21.1-4.21.23
8. Bélanger M, Magistretti PJ (2009) The role of astroglia in neuroprotection. Dialogues Clin Neurosci 11:281-295.
9. Bélanger M, Allaman I, Magistretti PJ (2011) Differential effects of pro-and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes. J Neurochem 116:564-576.
10. Brandt RB, Waters MG, Rispler MJ, Kline ES (1984) D-and L-lactate catabolism to CO2 in rat tissues. Proc Soc Exp Biol Med 175:328-335.
11. Brouwers O, Niessen PM, Ferreira I, Miyata T, Scheffer PG, Teerlink T, Schrauwen P, Brownlee M, Stehouwer CD, Schalkwijk CG (2011) Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation endproducts and oxidative stress in diabetic rats. J Biol Chem 286:1374-1380.
12. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264-278.
13. Chaplen FW, Fahl WE, Cameron DC (1996) Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture. Anal Biochem 238:171-178.
14. Chaplen FW, Fahl WE, Cameron DC (1998) Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc Natl Acad Sci U S A 95:5533-5538.
15. Chen F, Wollmer MA, Hoerndli F, Münch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Götz J (2004) Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A 101:7687-7692.
16. Chen YJ, Huang XB, Li ZX, Yin LL, Chen WQ, Li L (2010) Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. Eur J Pharmacol 645:1-8.
17. Chuquet J, Quilichini P, Nimchinsky EA, Buzsáki G (2010) Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. J Neurosci 30:15298-15303.
18. Déglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11:179-190.
19. Di Loreto S, Zimmitti V, Sebastiani P, Cervelli C, Falone S, Amicarelli F (2008) Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons. Int J Biochem Cell Biol 40:245-257.
20. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
21. Gavillet M, Allaman I, Magistretti PJ (2008) Modulation of astrocytic metabolic phenotype by proinflammatory cytokines. Glia 56:975-989.
22. Herrero-Mendez A, Almeida A, Fernández E, Maestre C, Moncada S, Bolaños JP (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/CCdh1. Nat Cell Biol 11:747-752.
23. Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 1147:61-69.
24. Kalapos MP (1999) Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 110:145-175.
25. Kalapos MP (2008a) Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabol Drug Interact 23:69-91.
26. Kalapos MP (2008b) The tandem of free radicals and methylglyoxal. Chem Biol Interact 171:251-271.
27. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW (2004) Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305:99-103.
28. Kikuchi S, Shinpo K, Moriwaka F, Makita Z, Miyata T, Tashiro K (1999) Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J Neurosci Res 57:280-289.
29. Kingkeohoi S, Chaplen FW (2005) Analysis of methylglyoxal metabolism in CHO cells grown in culture. Cytotechnology 48:1-13.
30. Koito W, Araki T, Horiuchi S, Nagai R (2004) Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem 136:831-837.
31. Kuhla B, Lüth HJ, Haferburg D, Boeck K, Arendt T, Münch G (2005) Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 1043:211-216.
32. Kuhla B, Boeck K, Lüth HJ, Schmidt A, Weigle B, Schmitz M, Ogunlade V, Münch G, Arendt T (2006) Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging 27:815-822.
33. Kuhla B, Boeck K, Schmidt A, Ogunlade V, Arendt T, Münch G, Lüth HJ (2007) Age-and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging 28:29-41.
34. Kumagai T, Nangaku M, Kojima I, Nagai R, Ingelfinger JR, Miyata T, Fujita T, Inagi R (2009) Glyoxalase I overexpression ameliorates renal ischemiareperfusion injury in rats. Am J Physiol Renal Physiol 296:F912-F921
35. Lüth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, Münch G (2005) Age-and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 15:211-220.
36. Magistretti PJ (2008) Brain energy metabolism. In: Fundamental neuroscience (Squire L, Bloom FE, Spitzer NC, du Lac S, Ghosh A, Berg D, eds), pp 271-292. San Diego: Academic
37. Magistretti PJ (2009) Role of glutamate in neuron-glia metabolic coupling. Am J Clin Nutr 90:875S-880S
38. Magistretti PJ, Pellerin L (1996) Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders. Ann N Y Acad Sci 777:380-387.
39. Matsumura H, Miyachi S (1980) Cycling assay for nicotinamide adenine dinucleotides. Methods Enzymol 69:465-470.
40. Miller AG, Smith DG, Bhat M, Nagaraj RH (2006) Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem 281:11864-11871.
41. Mitsumoto A, Kim KR, Oshima G, Kunimoto M, Okawa K, Iwamatsu A, Nakagawa Y (1999) Glyoxalase I is a novel nitric-oxide-responsive protein. Biochem J 344:837-844.
42. Morcos M, Du X, Pfisterer F, Hutter H, Sayed AA, Thornalley P, Ahmed N, Baynes J, Thorpe S, Kukudov G, Schlotterer A, Bozorgmehr F, El Baki RA, Stern D, Moehrlen F, Ibrahim Y, Oikonomou D, Hamann A, Becker C, Zeier M, et al. (2008) Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 7:260-269.
43. Münch G, Westcott B, Menini T, Gugliucci A (2010) Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids. Advance online publication. Retrieved October 2010. doi:10.1007/s00726-010-0777-y
44. Nagai R, Fujiwara Y, Mera K, Motomura K, Iwao Y, Tsurushima K, Nagai M, Takeo K, Yoshitomi M, Otagiri M, Ikeda T (2008) Usefulness of antibodies for evaluating the biological significance of AGEs. Ann N Y Acad Sci 1126:38-41.
45. Paoli T, Faulkner J, O'kennedy R, Keshavarz-Moore E (2010) A study of D-lactate and extracellular methylglyoxal production in lactate reutilizing CHO cultures. Biotechnol Bioeng 107:182-189.
46. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625-10629.
47. Porras OH, Loaiza A, Barros LF (2004) Glutamate mediates acute glucose transport inhibition in hippocampal neurons. J Neurosci 24:9669-9673.
48. Prapong T, Buss J, Hsu WH, Heine P, West Greenlee H, Uemura E (2002) Amyloid beta-peptide decreases neuronal glucose uptake despite causing increase in GLUT3 mRNA transcription and GLUT3 translocation to the plasma membrane. Exp Neurol 174:253-258.
49. Rabbani N, Thornalley PJ (2010) Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids. Advanced online publication. Retrieved October 2010. doi:10.1007/s00726-010-0783-0.
50. Ranganathan S, Walsh ES, Tew KD (1995) Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line. Biochem J 309:127-131.
51. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
52. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C (2008) Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322:1551-1555.
53. Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, Ibrahim Y, Pfisterer F, Rabbani N, Thornalley P, Sayed A, Fleming T, Humpert P, Schwenger V, Zeier M, Hamann A, Stern D, Brownlee M, Bierhaus A, Nawroth P, et al. (2009) C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 58:2450-2456.
54. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142-1147.
55. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62:5196-5203.
56. Thornalley PJ (1993) The glyoxalase system in health and disease. Mol Aspects Med 14:287-371.
57. Thornalley PJ (1996) Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 27:565-573.
58. Thornalley PJ (2008) Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 23:125-150.
59. Thornalley PJ, Tisdale MJ (1988) Inhibition of proliferation of human promyelocytic leukaemia HL60 cells by S-D-lactoylglutathione in vitro. Leuk Res 12:897-904.
60. Towne C, Aebischer P (2009) Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi. Methods Mol Biol 555:87-108.
61. Vargas MR, Johnson JA (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 11:e17
62. Vilchez D, Ros S, Cifuentes D, Pujadas L, Vallés J, García-Fojeda B, Criado-García O, Fernández-Sánchez E, Medraño-Fernández I, Domínguez J, García-Rocha M, Soriano E, Rodríguez de Córdoba S, Guinovart JJ (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10:1407-1413.
63. Wautier JL, Guillausseau PJ (2001) Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 27:535-542.
64. Wong A, Lüth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Münch G (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res 920:32-40.
65. Wu L, Eftekharpour E, Davies GF, Roesler WJ, Juurlink BH (2001) Troglitazone selectively inhibits glyoxalase I gene expression. Diabetologia 44:2004-2012.
66. Zerez CR, Lee SJ, Tanaka KR (1987) Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal Biochem 164:367-373.